Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell‐free DNA

Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell‐free DNA

Abstract Background Thromboembolism affects up to 30% of children undergoing treatment for acute lymphoblastic leukemia (ALL). Increased thrombin generation has been reported in ALL, but the mechanisms remain elusive. Objective We aimed to show that extracellular traps and cell‐free DNA (cfDNA) prom...

Full description

Bibliographic Details
Main Authors:	Rahul Kumar, Parmeshwar B. Katare, Steven R. Lentz, Arunkumar J. Modi, Anjali A. Sharathkumar, Sanjana Dayal
Format:	Article
Language:	English
Published:	Elsevier 2021-07-01
Series:	Research and Practice in Thrombosis and Haemostasis
Subjects:	cell‐free nucleic acids child extracellular traps induction chemotherapy leukemia thrombin generation
Online Access:	https://doi.org/10.1002/rth2.12557

Similar Items

Coagulation profile during induction chemotherapy in childhood acute lymphoblastic leukemia
by: Shivali Sehgal, et al.
Published: (2017-01-01)

Children with Standard Risk Acute Lymphoblastic Leukemia in Induction And Consolidation Phase
by: Adinugraha Amarullah, et al.
Published: (2018-04-01)

Clinical characteristics and outcomes of patients with pediatric acute lymphoblastic leukemia after induction of chemotherapy: a pilot descriptive correlational study from Palestine
by: Ramzi Shawahna, et al.
Published: (2021-07-01)

Etiology and Outcome of Seizures in Children during Induction Remission Chemotherapy for Acute Lymphoblastic Leukaemia
by: Shahinoor A. Soma, et al.
Published: (2022-06-01)

DNase 1 Protects From Increased Thrombin Generation and Venous Thrombosis During Aging: Cross‐Sectional Study in Mice and Humans
by: Rahul Kumar, et al.
Published: (2022-01-01)

Differences in Vitamin D Levels at Diagnosis and after Induction Phase Chemotherapy in Children with Acute Lymphoblastic Leukemia in Tertiary Hospital in West Java Indonesia
by: Wan Rita Mardhiya, et al.
Published: (2023-05-01)

Reduced‐dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B‐cell acute lymphoblastic leukemia
by: Jing Lu, et al.
Published: (2024-03-01)

Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia
by: Qingguo Liu, et al.
Published: (2020-07-01)

Orbital Myeloid Sarcoma in Acute Myeloid Leukemia: A Case Report
by: Kishalay Baidya, et al.
Published: (2022-12-01)

Multiple complications of the induction phase chemotherapy for childhood acute lymphoblastic leukemia
by: Dorota Jedlińska, et al.
Published: (2019-08-01)

Multiple complications of the induction phase chemotherapy for childhood acute lymphoblastic leukemia
by: Dorota Jedlińska, et al.
Published: (2019-08-01)

Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia
by: Sarah Robinson, et al.
Published: (2020-04-01)

Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia
by: Baohang Zhang, et al.
Published: (2023-05-01)

Resistance of t(17;19)‐acute lymphoblastic leukemia cell lines to multiagents in induction therapy
by: Atsushi Watanabe, et al.
Published: (2019-09-01)

Calcium ionophore-activated platelets induce eosinophil extracellular trap formation
by: Myeong Seong Sim, et al.
Published: (2023-07-01)

Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients
by: Julie Goswami, et al.
Published: (2021-12-01)

Encephalopathy and brain atrophy during induction chemotherapy in acute lymphoblastic leukemia
by: Qiao‐Ru Li, et al.
Published: (2020-09-01)

Association between TLR2 and TLR4 Expression and Response to Induction Therapy in Acute Myeloid Leukemia Patients
by: Mani Ramzi, et al.
Published: (2018-07-01)

Outcome of neutropenic enteropathy during induction phase of treatment of childhood acute lymphoblastic leukemia
by: Yesmin Tanjin Jahan, et al.
Published: (2023-12-01)

Differences in induction phase outcomes of acute lymphoblastic leukemia between well-nourished and malnourished pediatric patients
by: Meilani Puspasari Simarmata, et al.
Published: (2023-06-01)

Hidradenitis suppurativa in acute myeloid leukemia: Review of disease course and management
by: Stella X. Chen, MD, et al.
Published: (2022-01-01)

Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
by: Eréndira Mejía-Aranguré, et al.
Published: (2022-12-01)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
by: Elena Monzón Manzano, et al.
Published: (2020-10-01)

Evaluation of interleukin-35 and interleukin-10 in adult acute myeloid leukemia patients before and after induction chemotherapy
by: Eman Fadhil Mahmood, et al.
Published: (2020-01-01)

Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
by: Ki-Young Lee, et al.
Published: (2023-05-01)

Cytogenetics and Molecular Genetics in Pediatric Acute Lymphoblastic Leukemia (ALL) and Its Correlation with Induction Outcomes
by: Ajeitha Loganathan, et al.
Published: (2022-10-01)

Serum lactate dehydrogenase level in childhood acute lymphoblastic leukemia
by: Shaimaa Saad Abdul Zahra, et al.
Published: (2021-01-01)

Eruptive acral lentiginosis following chemotherapy for acute lymphoblastic leukemia: A case series
by: Cathal O’Connor, et al.
Published: (2021-10-01)

Thrombin Generation and Cancer: Contributors and Consequences
by: Caroline J. Reddel, et al.
Published: (2019-01-01)

Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
by: Fernanda Cristina Gontijo Evangelista, et al.
Published: (2022-06-01)

Infections During Induction Therapy of Protocol CCLG-2008 in Childhood Acute Lymphoblastic Leukemia: A Single-center Experience with 256 Cases in China
by: Si-Dan Li, et al.
Published: (2015-01-01)

Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective
by: Hiroshi Hayashi, et al.
Published: (2024-02-01)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
by: Patrycja Śliwa-Tytko, et al.
Published: (2022-05-01)

Impact of Delay Prior to Treatment in Ethiopian Children with Acute Lymphoblastic Leukemia
by: Hailu A, et al.
Published: (2023-05-01)

T Cell Subsets During Early Life and Their Implication in the Treatment of Childhood Acute Lymphoblastic Leukemia
by: Shanie Saghafian-Hedengren, et al.
Published: (2021-03-01)

Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study
by: Marco Picardi, et al.
Published: (2023-04-01)

Childhood B-lymphoblastic leukemia: Integrating cytogenetics with other prognostic parameters and correlation with post-induction remission
by: Neelum Mansoor, et al.
Published: (2023-09-01)

Chemoresponse of de novo Acute Myeloid Leukemia to “7+3” Induction can Be Predicted by c-Myc-facilitated Cytogenetics
by: Tzu-Hung Hsiao, et al.
Published: (2021-04-01)

Compliance with a protocol for acute lymphoblastic leukemia in childhood
by: Benigna Maria de Oliveira, et al.
Published: (2011-06-01)

Immature Reticulocyte Fraction and Absolute Neutrophil Count as Predictor of Hemopoietic Recovery in Patients with Acute Lymphoblastic Leukemia on Remission Induction Chemotherapy
by: Shan.e Rauf, et al.
Published: (2016-05-01)